Cargando…

Consensus-based statements for the management of mitochondrial stroke-like episodes

Background: Focal-onset seizures and encephalopathy are prominent features of a stroke-like episode, which is a severe neurological manifestation associated with subtypes of mitochondrial disease. Despite more than 30 years of research, the acute treatment of stroke-like episodes remains controversi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ng, Yi Shiau, Bindoff, Laurence A., Gorman, Gráinne S., Horvath, Rita, Klopstock, Thomas, Mancuso, Michelangelo, Martikainen, Mika H., Mcfarland, Robert, Nesbitt, Victoria, Pitceathly, Robert D. S., Schaefer, Andrew M., Turnbull, Doug M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7014928/
https://www.ncbi.nlm.nih.gov/pubmed/32090171
http://dx.doi.org/10.12688/wellcomeopenres.15599.1
Descripción
Sumario:Background: Focal-onset seizures and encephalopathy are prominent features of a stroke-like episode, which is a severe neurological manifestation associated with subtypes of mitochondrial disease. Despite more than 30 years of research, the acute treatment of stroke-like episodes remains controversial. Methods: We used the modified Delphi process to harness the clinical expertise of a group of mitochondrial disease specialists from five European countries to produce consensus guidance for the acute management of stroke-like episodes and commonly associated complications. Results: Consensus on a new definition of mitochondrial stroke-like episodes was achieved and enabled the group to develop diagnostic criteria based on clinical features, neuroimaging and/or electroencephalogram findings. Guidelines for the management of strokelike episodes were agreed with aggressive seizure management strongly recommended at the outset of stroke-like episodes. Conclusions: Our consensus statement defines stroke-like episodes in terms of an epileptic encephalopathy and we have used this to revise both diagnostic criteria and guidelines for management. A prospective, multi-centre, randomised controlled trial is required for evaluating the efficacy of any compound on modifying the trajectory of stroke-like episodes.